• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Research Updates: Delineating histologic prognostic factors for feline osteosarcoma

January 1, 2009
Joseph Harari, MS, DVM, DACVS

From this report, histologic analysis of tissues in cats with osteosarcoma will aid clinicians in providing a prognosis for owners, especially if incomplete surgical resection (unclean margins) occurs.

Although uncommon as a distinct clinical entity, osteosarcoma is the most frequently (70% to 80%) identified primary bone tumor in cats. Metastatic rates in cats (5% to 10%) are lower than those reported in dogs (80% to 90%), and wide surgical excision offers longer survival rates.

Joseph Harari

This retrospective study from two European veterinary schools evaluated the effects of histologic and clinical characteristics on prognosis for feline osteosarcoma, along with a histologic comparison to phenotypically similar canine osteosarcoma lesions. The authors reviewed the medical records of 62 cats (1994 to 2004) with histologically confirmed osteosarcoma and 22 dogs (1985 to 1999) with histologically confirmed skeletal osteosarcoma of the same location and subtype that corresponded to 22 of the feline skeletal osteosarcoma cases.

Advertisement

The study results revealed that the cats exhibited more axial (25) than appendicular (15) lesions and more skeletal (40) than extraskeletal (22) tumors. Results also revealed that feline osteosarcoma was most frequently identified in the maxilla (seven cases) and interscapular region (five cases) and that feline skeletal osteosarcoma was histologically similar to canine skeletal osteosarcoma. The cats had a tumor recurrence rate of 44% after surgery and a metastatic rate of 10%. A poorer prognosis was seen in cats with incomplete surgical resection, increased histologic grade, and increased mitotic index. Although vascular invasion by osteosarcoma was high in the cats in this study (82%) and is associated with a high-grade tumor and poor prognosis in dogs with osteosarcoma, it was not a significant prognosticator for feline osteosarcoma. The authors concluded that feline and canine skeletal osteosarcoma share similar histologic characteristics yet different prognostic characteristics.

COMMENTARY

In cats, axial osteosarcoma carries a poorer prognosis than appendicular or extraskeletal forms, probably because of difficulty in surgical excision. From this report, histologic analysis of tissues in cats with osteosarcoma will aid clinicians in providing a prognosis for owners, especially if incomplete surgical resection (unclean margins) occurs. Because feline osteosarcoma lesions have not been as frequently described as canine osteosarcoma lesions, reporting survival rates for patients in this study would have been beneficial.

Dimopoulou M, Kirpensteijn J, Moens H, et al. Histologic prognosticators in feline osteosarcoma: a comparison with phenotypically similar canine osteosarcoma. Vet Surg 2008;37(5):466-471.

The information in "Research Updates" was provided by Veterinary Medicine Editorial Advisory Board member Joseph Harari, MS, DVM, DACVS, Veterinary Surgical Specialists, 21 E. Mission Ave., Spokane, WA 99202.

Related Content:

OncologyFeline Medicine
Chronic feline pain from all perspectives
Chronic feline pain from all perspectives
Q&A with a keynote: Elizabeth Colleran, DVM, DABVP (Feline)
Q&A with a keynote: Elizabeth Colleran, DVM, DABVP (Feline)
UC Davis study on eye diseases in kittens
UC Davis study on eye diseases in kittens

Advertisement

Latest News

An update on copper concerns in pet foods

Dental hacks to make every case more manageable

Q&A with a keynote: Walter Brown, RVTg, VTS, ECC

News wrap-up: This week’s headlines, plus dvm360® launches its first CE podcast

View More Latest News
Advertisement